High Tech Pharm Co. Mutual Funds

Health Care & Life Sciences » Pharmaceuticals | High Tech Pharm Co. Ltd.

High Tech Pharm Co. Ltd. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

DFA Emerging Markets Small Cap Series

23,615

0.33%

01/31/2018

DFA Emerging Markets Core Equity Portfolio

21,787

0.31%

04/30/2018

DFA Emerging Markets Social Core Equity Portfolio

2,570

0.04%

04/30/2018

View Profile

Address	280 Sinnae-ro Eumseong-gun NC 27663 Korea, Republic Of
Employees	-
Website	http://www.htpharm.com
Updated	09/14/2018
High Tech Pharm Co., Ltd. engages in the manufacture and distribution of raw materials for injectable antibiotic products. Its products include imipenem, cilastatin sodium, blended imipenem-cilastatin sterile, meropenem, panipenem, and faropenem. The company was founded on September 1, 1998 and is headquartered in Eumseong, South Korea.